Shree Ganesh Bio-Tech Reports Q2 FY27 Net Loss Amid Revenue Drop
Shree Ganesh Biotech (India) Ltd · Financial Result · 02 Nov 2026, 10:58 pm
Shree Ganesh Bio-Tech Reports Q2 FY27 Net Loss Amid Revenue Drop Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹16.00 lakh for the quarter ended 30th Sep'26, falling 79.15% YoY from ₹76.74 lakh and 88.81% QoQ from ₹142.99 lakh. Total income reached ₹48.28 lakh, supported by ₹32.27 lakh in other income. Total expenses stood at ₹56.36 lakh, leading to a net loss of ₹8.08 lakh compared to a net profit of ₹1.41 lakh in Q2 FY26. For H1 FY27, revenue reached ₹158.99 lakh with a net loss of ₹65.40 lakh.
Original exchange filing (PDF)
More announcements from Shree Ganesh Biotech (India) Ltd
- PFA · 02 Nov 2026
- Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors .... · 02 Nov 2026
- Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Pursuant to Regulation .... · 02 Nov 2026
- PFA · 28 Sept 2026
- PFA · 28 Sept 2026
- Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial .... · 03 Sept 2026
- PFA · 03 Sept 2026
- PFA · 01 Sept 2026
